These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2013146)

  • 41. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents.
    Liu Y; Mentele LJ; McDonough RP; Carruthers KM; Doucette WR
    J Am Pharm Assoc (2003); 2008; 48(4):515-7. PubMed ID: 18653428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of coronary heart disease using risk factor categories.
    Wilson PW; D'Agostino RB; Levy D; Belanger AM; Silbershatz H; Kannel WB
    Circulation; 1998 May; 97(18):1837-47. PubMed ID: 9603539
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
    Talbert RL
    Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.
    Diller PM; Huster GA; Leach AD; Laskarzewski PM; Sprecher DL
    J Pediatr; 1995 Mar; 126(3):345-52. PubMed ID: 7869190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the new National Cholesterol Education Program (NCEP) guidelines on patient management.
    Harmel AP; Berra K
    J Am Acad Nurse Pract; 2003 Aug; 15(8):350-60. PubMed ID: 14509100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low total, low-density lipoprotein, high-density lipoprotein, and non-high-density lipoprotein cholesterol levels in patients with complex congenital heart disease after Fontan palliation.
    Whiteside W; Tan M; Yu S; Rocchini A
    J Pediatr; 2013 Jun; 162(6):1199-204. PubMed ID: 23312682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Davidson MH; Maki KC; Pearson TA; Pasternak RC; Deedwania PC; McKenney JM; Fonarow GC; Maron DJ; Ansell BJ; Clark LT; Ballantyne CM
    Am J Cardiol; 2005 Aug; 96(4):556-63. PubMed ID: 16098311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection and evaluation of dyslipoproteinemia.
    Cleeman JI
    Endocrinol Metab Clin North Am; 1998 Sep; 27(3):597-611, ix. PubMed ID: 9785055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of concordance in classification of coronary heart disease risk: high-risk HDL cholesterol less than 35 mg/dl in subjects with desirable total serum cholesterol, less than 200 mg/dl.
    Glueck CJ; Sanghvi VR; Laemmle P; Unger L; McCray C; Tracy T; Speirs J; Lang J; Tieger M; Kunkel R
    J Lab Clin Med; 1990 Sep; 116(3):377-85. PubMed ID: 2401850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening using National Cholesterol Education Program guidelines in a population of urban Hispanic mothers.
    Shea S; Basch CE; Zybert P; Rips J; Contento I; Gutin B; Irigoyen M
    Prev Med; 1989 Nov; 18(6):824-32. PubMed ID: 2626415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
    Nam BH; Kannel WB; D'Agostino RB
    Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    Manninen V; Tenkanen L; Koskinen P; Huttunen JK; Mänttäri M; Heinonen OP; Frick MH
    Circulation; 1992 Jan; 85(1):37-45. PubMed ID: 1728471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.